LUCENTIS® (ranibizumab) a Treatment Option for wAMD, DR & DME, mCNV, & RVO
Learn about LUCENTIS (ranibizumab injection), a treatment option for wet AMD, diabetic macular edema (DME), diabetic retinopathy (DR), mCNV, & RVO. See full safety for more information.
Keywords:
genentech, macular degeneration treatment, age-related macular degeneration, diabetic macular edema, lucentis, wet macular degeneration, lucentis injection, ranibizumab, macular edema, lucentis macular degeneration
Daily visitors:
534
Daily pageviews:
534
| Created: | 2003-04-25 |
| Expires: | 2024-04-25 |
| Owner: | Data protected, not disclosed |
| Hosting company: | CloudFlare, Inc. |
| Registrar: | Safenames Ltd. |
| IPs: | 104.18.16.77, 104.18.17.77 |
| DNS: |
alan.ns.cloudflare.com lara.ns.cloudflare.com |
| Email: | See owner's emails |
